Cargando…
CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients
Patients with UICC stage II colorectal cancer (CRC) have a risk of approximately 20% to develop disease recurrence after tumour resection. The presence and significance of micrometastases for locoregional recurrence in these patients lacking histopathological lymph node involvement on routine staine...
Autores principales: | Harder, J, Engelstaedter, V, Usadel, H, Lassmann, S, Werner, M, Baier, P, Otto, F, Varbanova, M, Schaeffner, E, Olschewski, M, Blum, H E, Opitz, O G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634714/ https://www.ncbi.nlm.nih.gov/pubmed/19142184 http://dx.doi.org/10.1038/sj.bjc.6604859 |
Ejemplares similares
-
CpG-island methylation study of liver fluke-related cholangiocarcinoma
por: Sriraksa, R, et al.
Publicado: (2011) -
Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location
por: Bae, J M, et al.
Publicado: (2013) -
NT5E CpG island methylation is a favourable breast cancer biomarker
por: Lo Nigro, C, et al.
Publicado: (2012) -
Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa
por: Belshaw, N J, et al.
Publicado: (2008) -
No association of CpG island methylator phenotype and colorectal cancer survival: population-based study
por: Jia, Min, et al.
Publicado: (2016)